Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study
Open Access
- 15 November 2021
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 15 (6), 867-877
- https://doi.org/10.5009/gnl20353
Abstract
Ju-Young Shin, Hye-Min Park, Min-Young Lee, Ja-Young Jeon, Hyun-Jeong Yoo, and Byong Duk Ye. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl20353Keywords
Funding Information
- Pfizer Pharmaceuticals Korea Ltd.
This publication has 33 references indexed in Scilit:
- Understanding and Preventing the Global Increase of Inflammatory Bowel DiseaseGastroenterology, 2017
- Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative ColitisPLOS ONE, 2016
- Anti TNF-α therapy for ulcerative colitis: current status and prospects for the futureExpert Review of Clinical Immunology, 2016
- Comorbidity Adjustment in Health Insurance Claim DatabaseHealth Policy and Management, 2016
- Changing epidemiological trends of inflammatory bowel disease in AsiaIntestinal Research, 2016
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3The American Journal of Gastroenterology, 2014
- Escalation to weekly dosing recaptures response in adalimumab‐treated patients with moderately to severely active ulcerative colitisAlimentary Pharmacology & Therapeutics, 2014
- Real‐world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2014
- Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past DecadeGastroenterology Research and Practice, 2013
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN studyGut, 2012